Accounts Payable Specialist at Abata Therapeutics

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalIndustries

Requirements

Bachelor’s degree in Accounting, Finance, or related field preferred
Minimum 2 years of accounts payable experience, ideally in the biotech or pharmaceutical industry
Experience working in a public company environment and familiarity with SOX compliance preferred
Proficiency with NetSuite is highly desirable. Experience with Prendio and Concur preferred
Strong attention to detail, organizational skills, and ability to meet deadlines
Proficiency in Microsoft Excel at an intermediate level preferred
Excellent communication and interpersonal skills
Demonstrated integrity and ability to handle confidential information
Ability to work independently and collaboratively in a team environment
United States work authorization required

Responsibilities

Process invoices, employee expense reports, and credit card transactions
Support 2-way and 3-way matching for Prendio procurement system invoice review
Prepare and process bi-weekly disbursements including initiating ACH and Wire payments
Maintain and reconcile accounts payable records in NetSuite and Prendio, ensuring timely and accurate data entry
Collaborate with internal departments and external vendors to resolve discrepancies and answer inquiries including payment updates
Support month-end and year-end closing activities, including journal entry accruals, reconciliations, and the year end 1099 process
Assist with audits by preparing documentation and responding to auditor requests
Ensure proper documentation and approval of all transactions in accordance with internal controls in a SOX environment
Monitor and maintain vendor records, including updating and validating vendor banking information
Identify and suggest process improvements to enhance efficiency and accuracy
Handle confidential financial information with discretion and integrity
Other duties as assigned

Skills

Accounts Payable

NetSuite

Prendio

Invoice Processing

Expense Reports

ACH Payments

Wire Payments

SOX Compliance

Vendor Management

Month-End Close

1099 Processing

Journal Entries

Reconciliations

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters

2021Year Founded

$184.8MTotal Funding

EARLY_VCCompany Stage

BiotechnologyIndustries

11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.

Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.

Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.

Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.

Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.

FDA's accelerated approval pathways may expedite Abata's clinical trials.

Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI

Try Jobo Free